Implementing a context-augmented large language model to guide precision cancer medicine.

Saved in:
Bibliographic Details
Title: Implementing a context-augmented large language model to guide precision cancer medicine.
Authors: Jun H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Tanaka Y; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Johri S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Harvard Medical School, Boston, MA 02115, USA., Carvalho FL; Department of Urology, Brigham and Women's Hospital, Boston, MA 02115, USA., Jordan AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Nagy M; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Boston Children's Hospital, Boston, MA 02115, USA., O'Meara TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Pappa T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Brigham and Women's Hospital, Boston, MA 02115, USA., Pimenta EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Saad E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Yang DD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA 02115, USA., Gillani R; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Harvard Medical School, Boston, MA 02115, USA.; Boston Children's Hospital, Boston, MA 02115, USA., Tewari AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Harvard Medical School, Boston, MA 02115, USA.; Brigham and Women's Hospital, Boston, MA 02115, USA., Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Van Allen E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Harvard Medical School, Boston, MA 02115, USA.; Lead contact.
Source: MedRxiv : the preprint server for health sciences [medRxiv] 2025 Jul 24. Date of Electronic Publication: 2025 Jul 24.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
DOI:10.1101/2025.05.09.25327312